We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH
RNS Number : 6679O
Dechra Pharmaceuticals PLC
08 November 2016
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) --------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Dechra Pharmaceuticals the underlying issuer PLC of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------ ------------------------------------- 2. Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------- ------------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------- ------------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------- ------------------------------------ An event changing the breakdown of voting rights ------------------------------------------------------------- ------------------------------------ Other (please specify): ----------------------------------------------------------- ------------------------------------ 3. Full name of person(s) Aberdeen Asset Managers Limited subject to the (and/or acting for its affiliates) notification obligation: as discretionary investment (iii) manager on behalf of multiple managed portfolios ------------------------------------------------------------ ------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ------------------------------------------------------------ ------------------------------------- 5. Date of the transaction 7 November 2016 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------ ------------------------------------- 6. Date on which issuer 8 November 2016 notified: ------------------------------------------------------------ ------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ------------------------------------------------------------ ------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ---------------- -------------- ------------------------ ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------ -------------- --------- ------------- ------------ ----------- GB0009633180 4,855,419 4,656,592 4,786,478 4,587,651 4.94% ------------- ---------------- ---------------- -------------- --------- ------------- ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- -------------- ---------------- -------------------------- ----------------------- Nominal Delta --------------- -------------- -------------- ---------------- -------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------- ----------------------------------------------------------------- 4,587,651 4.94% --------------------------------------------------- ----------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------------- Proxy Voting: ----------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- -------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- -------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- -------------------- 13. Additional information: ------------------------------------------------------------- -------------------- 14. Contact name: Ben Van Loon ------------------------------------------------------------- -------------------- 15. Contact telephone number: +44(0)1224 404090 ------------------------------------------------------------- --------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLDMMGMVRKGVZM
(END) Dow Jones Newswires
November 08, 2016 11:46 ET (16:46 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions